A daily dose of an oral antiretroviral drug, currently approved to treat HIV infection, reduced the risk of acquiring HIV infection by 43.8 percent among men who have sex with men. The findings, a major advance in HIV prevention research, come from a large international clinical trial published online Nov. 23 by the New England Journal of Medicine. The study, titled “Chemoprophylaxis for HIV Prevention in Men,” found even higher rates of effectiveness, up to 72.8 percent, among those participants who adhered most closely to the daily drug regimen.

BANGKOK, 5 November 2010 (IRIN) – Health experts in Thailand say the odds are stacked against them in combating one of the highest HIV prevalence rates in Asia, with only 2 percent of the country’s AIDS budget going on condoms.

http://www.cdc.gov/hiv/idu/resources/slides/slides/idu.ppt Slide 1 HIV Surveillance in Injection Drug Users (IDU) PDF File or PPT File Slide 2 Diagnoses of HIV Infection among Adults and Adolescents, by Transmission Category, 2005–2008—37 States and 5 U.S. Dependent Areas PDF File or PPT File Slide 3 Diagnoses of HIV Infection among Adults and Adolescents, by Sex and Transmission Category, 2008 —37 [...]

Miami-Dade health officials announced the first locally acquired case of dengue fever in decades. They also warned about Eastern Equine Encephalitis, cholera — and hookworm on Miami Beach sands.

Read more: http://www.miamiherald.com/2010/11/11/1921775/1-case-of-dengue-fever-reported.html#ixzz155y9rIhW